Chris Freeman
Chief Commercial Officer · 3 filings · Latest: Apr 1, 2026
Guardant Health, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GH | Chris Freeman | Chief Commercial Officer | Apr 1, 2026 | Option Exercise | $0.00 | 11,213 | — | 64,784 | |
GH | Chris Freeman | Chief Commercial Officer | Mar 15, 2026 | Option Exercise | $0.00 | 16,828 | — | 60,698 | |
GH | Freeman Chris | — | Dec 5, 2025 | Proposed Sale | $103.07 | 31,452 | $3.2M | — |